Because only limited information about the effects of RGSE on PON activity and on its relationships with apo-AI and HDL-C levels is available, this study was carried out to determine the effects of RGSE supplementation on the lipid profile, apo-AI levels and PON activity in patients with mild to moderate hyperlipidemia (MMH). This evidence concerns the gene PON1 and hyperlipidemia.